FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

NCS Healthcare of Kentucky Buspirone Hydrochloride Tabs 10 mg Recall

Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-…

NCS Healthcare of Kentucky Inc · Glasgow, KY

Risk level
Class III
Reported by FDA
Nov 29, 2023
Recall ID
D-0113-2024
Check your lot numberHow we source this data

Summary

NCS Healthcare of Kentucky recalled Buspirone Hydrochloride Tabs 10 mg starting Oct 27, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0113-2024 on Nov 29, 2023. Reason: Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

Product description

Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.

Lot numbers, UPCs & expiration codes

Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0113-2024
Classification
Class III
Status
Terminated
Recall initiated
Oct 27, 2023
FDA report date
Nov 29, 2023
Quantity
1,344 cards
Recall type
Voluntary: Firm initiated
Recalling firm
NCS Healthcare of Kentucky Inc

Original FDA data

Every field from FDA enforcement report D-0113-2024, exactly as published.

Show all FDA fields
City
Glasgow
State
KY
Status
Terminated
Country
United States
Event ID
93336
Address
120 Carroll Knicely Dr
Code information
Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024
Postal code
42141-7224
Report date
Nov 29, 2023
Product type
Drugs
Recall number
D-0113-2024
Classification
Class III
Recalling firm
NCS Healthcare of Kentucky Inc
Product quantity
1,344 cards
Termination date
Jul 14, 2024
Reason for recall
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Voluntary / mandated
Voluntary: Firm initiated
Product description
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.
Distribution pattern
Nationwide USA
Recall initiation date
Oct 27, 2023
Initial firm notification
Letter
Center classification date
Nov 21, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0113-2024, published Nov 29, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls